RESECTABLE NON-SMALL CELL LUNG CANCER
Clinical trials for RESECTABLE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer combo therapy aims to clear tumors before surgery
Disease control Not yet recruitingThis phase II trial investigates whether combining the immunotherapy adebelizumab with other anti-tumor drugs, given before and after surgery, can improve outcomes for people with resectable non-small cell lung cancer. The study enrolls adults aged 18-70 with stage II or IIIA dis…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New triple therapy aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with early-stage lung cancer that can be removed by surgery. The treatment combines NK cells (a type of immune cell), an immunotherapy drug (PD-1 antibody), and standard chemotherapy given before surgery. The main goals are …
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC